NGeneBio participated in MEDLAB 2024, the world's largest medical laboratory industry event, held in Dubai from February 5th to 8th, 2024.

At this exhibition, NGeneBio focused on showcasing NGeneAnalySys™, a genome analysis solution based on NGS  technology, 

optimized for both on-premise and SaaS type of solution

Moreover, the company actively engaged in meetings with numerous international buyers and corporate stakeholders

to explore partnerships and new deals in the Middle East and Africa regions.

Leveraging diverse global networks, NGeneBio is planning to swiftly advance its presence in the high-growth potential Middle East market.